Slideshows Images Quizzes


Last reviewed on RxList: 10/5/2017
Travatan Side Effects Center

Last reviewed on RxList 10/05/2017

Travatan (travoprost) Ophthalmic Solution 0.004% reduces pressure in the eye by increasing the amount of fluid that drains from the eye and is used to treat certain types of glaucoma and other causes of high pressure inside the eye. Common side effects of Travatan include:

  • blurred vision,
  • eye redness/discomfort/itching,
  • feeling as if something is in your eye,
  • stinging or burning of the eyes after using the drops,
  • dry or watery eyes,
  • tearing,
  • eyelid crusting,
  • increase in eyelash number/length/thickness,
  • darkening of the eyelashes and eyelids,
  • increased sensitivity to light, and
  • headache.

Travatan may slowly (over months to years) cause brown discoloration of the colored portion of the eye (iris). This color change may be permanent, but the long-term effects are uncertain. Tell your doctor if this occurs. Tell your doctor if you have unlikely but serious side effects of Travatan including:

  • vision changes,
  • eye pain, or
  • swelling or redness of the eyelids.

The recommended dosage is one drop of Travatan in the affected eye(s) once daily in the evening. There may be other drugs that can affect Travatan. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. Travatan should be used only when prescribed during pregnancy. It is not known if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Travatan (travoprost) Ophthalmic Solution 0.004% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Travatan Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using travoprost ophthalmic and call your doctor at once if you have any of these serious side effects:

  • redness, swelling, itching, or pain in or around your eye;
  • oozing or discharge from your eye;
  • increased sensitivity to light;
  • vision changes; or
  • chest pain.

Less serious side effects may include:

  • mild eye discomfort;
  • headache;
  • feeling like something is in your eye;
  • blurred vision;
  • dry or watery eyes; or
  • stinging or burning of the eyes after using the drops.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Travatan (Travoprost)

Travatan Professional Information


Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The most common adverse reaction observed in controlled clinical trials with TRAVATAN® (travoprost ophthalmic solution) 0.004% and TRAVATAN Z® (travoprost ophthalmic solution) 0.004% was ocular hyperemia which was reported in 30% to 50% of patients. Up to 3% of patients discontinued therapy due to conjunctival hyperemia. Ocular adverse reactions reported at an incidence of 5% to 10% in these clinical trials included decreased visual acuity, eye discomfort, foreign body sensation, pain and pruritus.

Ocular adverse reactions reported at an incidence of 1% to 4% in clinical trials with TRAVATAN® or TRAVATAN Z® included abnormal vision, blepharitis, blurred vision, cataract, conjunctivitis, corneal staining, dry eye, iris discoloration, keratitis, lid margin crusting, ocular inflammation, photophobia, subconjunctival hemorrhage and tearing.

Nonocular adverse reactions reported at an incidence of 1% to 5% in these clinical studies were allergy, angina pectoris, anxiety, arthritis, back pain, bradycardia, bronchitis, chest pain, cold/flu syndrome, depression, dyspepsia, gastrointestinal disorder, headache, hypercholesterolemia, hypertension, hypotension, infection, pain, prostate disorder, sinusitis, urinary incontinence and urinary tract infections.

Postmarketing Experience

Additional adverse reactions have been identified during post approval use of TRAVATAN® or TRAVATAN Z® in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to TRAVATAN® or TRAVATAN Z®, or a combination of these factors, include: arrhythmia, vomiting, epistaxis, tachycardia, and insomnia.

In postmarketing use with prostaglandin analogs, periorbital and lid changes including deepening of the eyelid sulcus have been observed.

Read the entire FDA prescribing information for Travatan (Travoprost)

Related Resources for Travatan

Related Health

Read the Travatan User Reviews »

© Travatan Patient Information is supplied by Cerner Multum, Inc. and Travatan Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors